ESE. K. Shushakova

E. K. Shushakova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


E. K. Shushakova has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Rational approaches to therapy for combined urogenital infections in married couples

    by E. K. Shushakova, N. A. Meshkova, T. A. Ruzhentsova

    The purpose of the study. The aim of the study was to evaluate the effectiveness of antiviral therapy in urogenital infection caused by the herpes simplex virus in combination with human papillomavirus (HSV‑1, -2 and HPV) in couples with impaired reproductive function.Materials and methods. The study included 149 married couples with complaints about the absence or pathological course of pregnancy with termination in the first trimester. Urogenital infection caused by the herpes simplex virus was detected in 80 couples. A combination with human papillomavirus was detected in 36 cases. The effectiveness of antiviral therapy was evaluated.Results. After the first course of treatment with the use of an antiherpetic drug in 80 couples who had manifestations of active herpes infection, pregnancy and the birth of a healthy child were registered in 44 cases (55%). Combination therapy with acyclovir or valacyclovir and inosine pranobex was required, which led to a positive dynamic of indicators in case of a combined infection. The onset and normal course of pregnancy were registered after treatment in 33% of couples in this group.Conclusions. A possible cause of reproductive dysfunction with the absence or termination of pregnancy in the early stages may be a urogenital infection caused by HSV types 1, 2. In most cases, antiviral therapy promotes the birth of a healthy child. The ineffectiveness of therapy may be associated with the simultaneous presence of two or more infectious significant agents. For the treatment of couples who have an active persistence of HSV‑1, -2 in combination with HPV, the appointment of inosine pranobex in combination with acyclovir or valacyclovir is recommended.

  • Open Access

    Clinical efficacy of using bacterial lysates in treatment of recurrent respiratory tract infections in children

    by S.V. Nikolaeva, O.O. Pogorelova, E.K. Shushakova

    Клиническая эффективность использования бактериальных лизатов в терапии рецидивирующих респираторных инфекций у детей

  • Herpesvirus infections in ARVI episodes in children

    by T.A. Ruzhentsova, R.V. Popova, Mytishchi Mytishchi Regional Clinical Hospital, A.A. Garbuzov, E.K. Shushakova, I.N. Khalyastov, N.A. Meshkova

    Aim: to evaluate the detection rate of the herpesvirus activity in children with acute respiratory viral infection (ARVI) signs for determination of the optimal treatment tactics. Patients and Methods: the study included 1120 children aged 3 to 18 years (mean age 7.48±3.91 years) who were observed on an outpatient basis (n=650) or hospitalized (n=379) due to the lack of improvement on the 3rd day after the first ARVI symptoms onset (n=1029) or due to the detected complication (n=91). The herpesvirus DNA was detected in throat swabs by PCR. Enzyme immunoassay was used to evaluate the levels of IgG, IgM, and IgA antibodies. Results: the presence of IgG antibodies to at least one of the herpes viruses was detected in 1097 (97.9%) of patients: in the children group over 6 years old in 723 (100%) patients. The presence of herpesvirus DNA in smears from the posterior pharyngeal wall and tonsils was detected in 234 (20.9%) children: 178 (15.9%) — isolated, 56 (5.0%) — in various combinations. IgM antibodies to Epstein-Barr virus and cytomegalovirus were detected in all cases in the herpesvirus DNA presence in the blood. The herpes simplex virus DNA has not been detected in any case. However, antibodies were detected in 63 (5.6%) children: IgA in 57 (5.1%) and IgM in 6 (0.5%) children. Conclusions: in children with ARVI symptoms, signs of an active infection caused by one or another type of herpes were detected in 26.5% of cases, and in 5% — their combination. The high prevalence of the herpesvirus activity comparable with the detection rate of seasonal respiratory viral infections, along with the adverse effect of herpesvirus infection on the immune system with the severe somatic pathology probability, necessitates the use of a drug with a wide spectrum of antiviral action for the ARVI signs in children — inosine pranobex. In the presence of complications caused by herpesvirus, inosine pranobex does not cause negative trend of antibody activity indicators, inosine pranobex, Groprinosin® KEYWORDS: HHV-6, human herpesvirus type 6, herpes simplex virus, Epstein-Barr virus, herpes, herpesvirus infection, herpes infection, ARVI, cytomegalovirus, inosine pranobex, Groprinosin. FOR CITATION: Ruzhentsova T.A., Popova R.V., Garbuzov A.A., Shushakova E.K., Khalyastov I.N., Meshkova N.A. Herpesvirus infections in ARVI episodes in children. Russian Journal of Woman and Child Health. 2023;6(4):399–404 (in Russ.). DOI: 10.32364/2618-8430- 2023-6-4-12.


  • Open Access

    Features of the course of influenza and its co-infection in children at the present stage

    by С.в. Николаева, Д.в. Усенко, O.O. Pogorelova, S. V. Shabalina, Yu. N. Khlypovka, E.K. Shushakova, O. V. Rubleva

    Influenza is an acute respiratory infection, mainly affecting the respiratory tract (often the trachea), with a tendency to develop symptoms rapidly and in most cases not requiring hospitalization. All acute respiratory infections are non-specific, with symptoms of intoxication, catarrhal symptoms (nasal congestion, rhinorrhoea, sore throat or pharyngeal discomfort), fever and cough. Improvement and widespread implementation of molecular methods to identify respiratory pathogens has led to the establishment of a higher frequency of co-infections. A literature review of the frequency of influenza co-infections is presented. Clinical cases of monoinfluenza and co-infections of influenza and respiratory syncytial infection are described, demonstrating the antagonistic effect of the two viruses on the course of the disease. In the first case, the patient, 1 year 1 month old, was hospitalised with a fever of 39 ºC in a moderate condition. A nasopharyngeal swab showed RNA of influenza A virus by PCR and was diagnosed with influenza. In the second case, the patient, 2 years old, at the beginning of the disease complained of an increase in body temperature to 38.7 ºC, cough, and difficulty in nasal breathing. On admission, the patient was in moderate condition with a body temperature of 36.6 ºC, clear consciousness and well-being. On auscultation, breathing in the lungs was rigid, single moist rales, scattered on both sides. A nasopharyngeal swab showed RNA of influenza A virus and respiratory syncytial virus by PCR. A viral acute respiratory infection of combined etiology and acute bronchitis was diagnosed. In the third case, a 14-year-old patient presented with complaints of fever up to 39 ºC, headache, weakness, muscle pain, dry cough. The condition was of moderate severity. The diagnosis of influenza A was confirmed by a rapid test for influenza A/B/C. In the treatment and prevention of both monoinfection and co-infections of influenza and other viruses, these clinical examples demonstrate the effectiveness of oseltamivir. These clinical examples highlight some key parameters: respiratory co-infections change the typical clinical picture of the disease, making it difficult to clinically diagnose the infection, highlighting laboratory diagnosis, which in turn facilitates rapid verification of the diagnosis and timely prescription of adequate therapy.


  • Symptoms of herpesvirus infection in reproductive disorders in married couples

    by E.K. Shushakova, V.S. Markina, S.V. Nikolaeva, T.A. Ruzhencova

    The aim of the study was to determine the clinical and laboratory features of the course of herpetic infection in married couples with impaired reproductive function. Patients and methods. The study by continuous screening included 149 married couples who complained of reproductive dysfunction. The main group included 80 married couples who had signs of urogenital herpetic infection, and the comparison group consisted of 69 married couples who did not have markers of HSV-1, 2 infection. Clinical, laboratory and ultrasound deviations were evaluated in the compared groups. It was revealed that 58.75% of patients from the main group and 38.75% in the comparison group had various complaints when assessing the symptoms among women. 43.75% of patients complained among men of the main group, and in the comparison group – 6.25%. Gynecological examination of women with HSV-1, 2 more often revealed cracks in the posterior adhesions, vesicular erosive elements of the external genitalia, contact bleeding, enlargement of the uterus and enlargement of inguinal lymph nodes. Laboratory examination of the spermogram in the vast majority of patients of the main group revealed teratozoospermia. Detection of HSV-1, 2 by the culture method in 100% of cases, along with the detection of antibodies of class IgA or IgM (less often) confirms infection. It was concluded that it is necessary to take into account the probability of damage to the urogenital tract of HSV-1, 2 when examining couples with reproductive disorders in the form of infertility or undeveloped pregnancy. Complaints, anamnesis and examination data should be taken into account to confirm or exclude significant infection with herpes simplex virus. The most informative are the culture method, as well as serological with the detection of IgA class antibodies among the laboratory methods for assessing the significance of infection associated with HSV-1, 2. Couples should be prescribed antiherpetic therapy if infection is confirmed.

  • Features of influenza’s course in combination with other viruses in children

    by S. V. Nikolaeva, Yu. N. Khlypovka, E. K. Shushakova, N. A. Meshkova, D. A. Khavkina, P. V. Chukhliaev, T. A. Ruzhentsova, Ю. Н. Хлыповка

    The objective. To evaluate the frequency and laboratory characteristics of pneumonia in children when influenza is combined with other respiratory viruses.Materials and methods. We examined 72 children aged 1 month to 17 years who were hospitalized in a specialized hospital in 2017–2019 with influenza type A (72 %) or B (28 %). The main group included 36 patients who had a laboratory-confirmed combination of influenza with other respiratory viruses, and the comparison group included 36 cases in which influenza was the only pathogen detected.Results. The analysis of the frequency of complications showed that in the main group, pneumonia developed significantly more often – in 22 % (8 children), and in the comparison group – in 6 % (2 children, p < 0.05).Conclusions. 1) The combination of influenza with other respiratory viruses is a risk factor for the development of pneumonia in children. 2) There are no significant changes in the indicators of clinical blood analysis in pneumonia developing against the background of influenza, including in combination with other respiratory viruses.


  • Importance of herpes simplex virus in development of infertility in married couples

    by E. K. Shushakova, N. A. Meshkova, D. A. Khavkina, P. V. Chukhliaev, T. A. Ruzhentsova

    The article considers the role of herpes simplex viruses of 1st, 2nd types in the development of reproductive disorders in married couples. The clinical example shows the difficulties of diagnosis, possible errors in treatment approaches, and the lack of results from the use of artificial insemination methods in the presence of persistent herpetic infection. Prolonged antiviral therapy led to the onset of pregnancy and the birth of a child.


  • Open Access

    РОЛЬ ДЕЗИНТОКСИКАЦИОННОЙ И АНТИОКСИДАНТНОЙ ТЕРАПИИ В ЛЕЧЕНИИ COVID-19: ТЕОРИЯ И ПРАКТИКА

    by Дарья Хавкина, Татьяна Руженцова, Павел Чухляев, Александр Гарбузов, Екатерина Шушакова

    Проанализировано более 30 литературных источников, содержащих данные о течении, диагностике и терапии Covid-19. Ни в одном источнике не упоминается о дезинтоксикационной и/или антиоксидантной терапии. Проанализированы три клинических случая COVID-19. На основе собственной клинической практики сформирована модель патогенеза COVID-19, которая обосновывает необходимость применения препаратов – дезинтоксикантов, сорбентов и антиоксидантов, как улучшающих течение, прогноз и исход заболевания. Клинические примеры, указанные в статье демонстрируют эффективность предложенной терапии. Сформированная модель патогенеза COVID-19 обоснована клинически и патофизиологически.